) has been revised to $8.16 / share. This is a decrease of 27.27% from the prior estimate of $11.22 dated November 7, 2025. The price target is an average of many targets provided by analysts. The ...
The average one-year price target for GT Biopharma (NasdaqCM:GTBP) has been revised to 153.00 / share. This is an increase of 2,900.00% from the prior estimate of 5.10 dated January 16, 2024. The ...
Goodyear Tire & Rubber is back in focus as its updated fair value estimate moves from US$9.76 to US$8.94, trimming the ...
Honda just pulled the cover off of a new racing car concept aimed at joining next year’s Japanese Super GT Championship during the ongoing Tokyo Auto Salon. Known as the Honda Civic Type R-GT Concept, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results